Fuzeons kliniske aktivitet (i kombination med andre antiretrovirale stoffer) på plasma- hiv- RNA - koncentrationer og CD4- tal er undersøgt i to randomiserede, kontrollerede multicenterstudier (TORO 1 og TORO 2) af 48 ugers varighed.
The clinical activity of Fuzeon (in combination with other antiretroviral agents) on plasma HIV RNA levels and CD4 counts have been investigated in two randomised, multicenter, controlled studies (TORO 1 and TORO 2) of Fuzeon of 48 weeks duration.